Feasibility of Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations
Sponsor study identifier
observational
65
1 country
1
Study Start
November 22, 2011
Actual (reported)Primary Completion
October 21, 2019
Actual (reported)Study Completion
October 21, 2019
Actual (reported)"A treatment session especially for PLWHA to help them discuss and take action about their smoking may be useful."
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 21, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 22, 2011
Actual (reported)November 28, 2011
Actual (reported)December 1, 2011
Actual (reported)October 21, 2019
Actual (reported)October 21, 2019
Actual (reported)Feasibility of a motivational tobacco cessation intervention
The study will test whether the percentage of eligible and enrolled study participants who complete the assigned intervention is significantly different from a population of percentages centered at 45%, i.e., the "null population percentage," considered a percentage too low to be compatible with feasibility."
2 years
Estimate the differences between the experimental intervention
2 years
This study is a pilot intervention trial examining the feasibility of a motivational smoking cessation intervention using respiratory biomarker feedback in low income PLWHA. The plan is to recruit a pilot sample of 50 eligible and consented participants, randomized at a 1:1 ratio into either the Treatment As Usual (TAU) condition or the experimental (Aspiration, Inspiration Respiration, or AIR) intervention condition.
This study is a pilot intervention trial examining the feasibility of a motivational smoking cessation intervention using respiratory biomarker feedback in low income PLWHA. The plan is to recruit a pilot sample of 50 eligible and consented participants, randomized at a 1:1 ratio into either the Treatment As Usual (TAU) condition or the experimental (Aspiration, Inspiration Respiration, or AIR) intervention condition.
Participants in the Treatment as Usual study arm will be provided with the following: 1) brief smoking cessation counseling as recommended in the Public Health Service treatment guidelines; 2) direct referral to the NY/NJ State Quitline; 3) a brochure that describes the Quitline services and provides contact information via telephone or internet; 4) a NY State brochure on HIV and smoking that identifies the specific risks of smoking for PLWHA; and 5) referral assistance to participants who present with untreated co-morbid conditions.
"Low-income smokers living with HIV/AIDS being served at community-based organizations."
City College of New York
New York, New York, 10031, United States
Jamie Ostroff, PhD
Memorial Sloan Kettering Cancer Center
65 participants (actual enrollment reported by the registry).
First Submitted
November 28, 2011
First Posted
December 1, 2011
Study Start
November 22, 2011
Actual (reported)Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men
Participants in the Aspirations, Inspiration, and Respiration study arm will receive all of the components of Treatment as Usual along with these additional components: 1) a lung age test to determine the ability and functioning of their lungs; 2) a personal lung health report with their lung age, the CO level of their breath, and a summary of their respiratory symptom assessment; 3) a review of this personal lung health report with a study counselor, 4) motivational interviewing techniques guided by Self-Determination Theory concepts to explicitly elicit at least one life aspiration of the patient and encourage discussion of such aspirations using an autonomy-supportive approach.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
October 21, 2019
Actual (reported)Study Completion
October 21, 2019
Actual (reported)Last Updated
November 4, 2019
Record last verified: 2019-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: